Drug Shortage Report for LEUCOVORIN CALCIUM INJECTION

Last updated on 2023-03-23 History
Report ID 184317
Drug Identification Number 02087316
Brand name LEUCOVORIN CALCIUM INJECTION
Common or Proper name LEUCOVORIN CALCIUM INJECTION
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) LEUCOVORIN
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 1
ATC code V03AF
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2023-02-15
Actual start date
Estimated end date 2023-03-15
Actual end date 2023-03-22
Shortage status Resolved
Updated date 2023-03-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2023-03-23 English Compare
v5 2023-03-22 French Compare
v4 2023-03-22 English Compare
v3 2023-02-16 English Compare
v2 2023-02-10 French Compare
v1 2023-02-10 English Compare

Showing 1 to 6 of 6